Kelly Thomas Patrick bought XENE
September 30, 2026 · Form 4 insider transaction
Kelly Thomas Patrick bought 15,000 shares of Xenon Pharmaceuticals Inc. at $37.32 per share, a transaction worth $559.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$37.32
Total value
$559.7K
InsiderKelly Thomas Patrick
RoleOfficer
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateSeptember 30, 2026
Filing dateOctober 1, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo